NASDAQ:MIRM

Mirum Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy MIRM

*Your capital is at risk

$91.84

-0.335 (-0.363%)

At Close: Jun 03, 2026

Mirum Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -1.73. In total, the insiders bought 1.17M and sold 157.01K MIRM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-1.73
● Buy	1.17M shares
● Sell	157.01K shares
72% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence Jan 28, 2026 Analysis Breakdown: Weakened by a contradictory negative Insider Power Score. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 16, 2026 Sell	Common Stock S-Sale	Bjerkholt Eric Chief Financial Officer	C-Suite Officer	7 287 Value: $670.2K
Mar 16, 2026 Buy	Stock Option (right to buy) M-Exempt	Ramasastry Saira Director	Director	2 000 Value: $47.0K
Mar 16, 2026 Buy	Common Stock M-Exempt	Ramasastry Saira Director	Director	2 000 Value: $47.0K
Mar 16, 2026 Sell	Common Stock S-Sale	Peetz Christopher Chief Executive Officer	CEO / President	40 985 Value: $3.77M
Mar 16, 2026 Sell	Common Stock S-Sale	Ramasastry Saira Director	Director	2 000 Value: $181.5K
Mar 16, 2026 Sell	Common Stock S-Sale	Radovich Peter President And COO	CEO / President	16 515 Value: $1.52M
Mar 15, 2026 Buy	Common Stock M-Exempt	Peetz Christopher Chief Executive Officer	CEO / President	50 000 Value: $4.59M
Mar 15, 2026 Buy	Performance Restricted Stock Units M-Exempt	Howe Jolanda SVP, Global Controller	Officer	2 658 Value: $244.1K
Mar 15, 2026 Buy	Performance Restricted Stock Units M-Exempt	Howe Jolanda SVP, Global Controller	Officer	6 000 Value: $551.0K
Mar 15, 2026 Buy	Common Stock M-Exempt	Howe Jolanda SVP, Global Controller	Officer	2 658 Value: $244.1K
Mar 15, 2026 Buy	Common Stock M-Exempt	Howe Jolanda SVP, Global Controller	Officer	6 000 Value: $551.0K
Mar 15, 2026 Buy	Performance Restricted Stock Units M-Exempt	Radovich Peter President And COO	CEO / President	7 220 Value: $663.0K
Mar 15, 2026 Buy	Common Stock M-Exempt	Quan Joanne Chief Medical Officer	Officer	13 334 Value: $1.22M
Mar 15, 2026 Buy	Performance Restricted Stock Units M-Exempt	Bjerkholt Eric Chief Financial Officer	C-Suite Officer	13 334 Value: $1.22M
Mar 15, 2026 Buy	Performance Restricted Stock Units M-Exempt	Peetz Christopher Chief Executive Officer	CEO / President	25 000 Value: $2.30M
Mar 15, 2026 Buy	Performance Restricted Stock Units M-Exempt	Peetz Christopher Chief Executive Officer	CEO / President	50 000 Value: $4.59M
Mar 15, 2026 Buy	Common Stock M-Exempt	Bjerkholt Eric Chief Financial Officer	C-Suite Officer	13 334 Value: $1.22M
Mar 15, 2026 Buy	Performance Restricted Stock Units M-Exempt	Quan Joanne Chief Medical Officer	Officer	13 334 Value: $1.22M
Mar 15, 2026 Buy	Common Stock M-Exempt	Peetz Christopher Chief Executive Officer	CEO / President	25 000 Value: $2.30M
Mar 15, 2026 Buy	Common Stock M-Exempt	Radovich Peter President And COO	CEO / President	23 000 Value: $2.11M
Mar 15, 2026 Buy	Common Stock M-Exempt	Radovich Peter President And COO	CEO / President	7 220 Value: $663.0K
Mar 15, 2026 Buy	Performance Restricted Stock Units M-Exempt	Radovich Peter President And COO	CEO / President	23 000 Value: $2.11M
Mar 06, 2026 Buy	Stock Option (right to buy) M-Exempt	Radovich Peter President And COO	CEO / President	5 912 Value: $93.8K
Mar 06, 2026 Buy	Common Stock M-Exempt	Radovich Peter President And COO	CEO / President	5 912 Value: $93.8K
Feb 13, 2026 Buy	Stock Option (right to buy) M-Exempt	Ramasastry Saira Director	Director	2 000 Value: $47.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MIRUM PHARMACEUTICALS, INC.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment o...

Read Full Profile Here